Lexeo Therapeutics Ownership & Insider Activity

Lexeo Therapeutics (LXEO) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.3% of shares outstanding. Institutional investors hold 33.4%. Over the past 90 days, insiders made 3 sales worth $43K.

Shares Outstanding

82.088M

Shares Float

70.364M

Insider Shares Owned

988.235K

Insider % Owned

1.3%

Institutional Shares Held

27.455M

Institutional % Held

33.4%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$43K total

Net Activity

Net Selling

Net Value (90d)

-$43K

Lexeo Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 18, 2026	Edward Louis Tamayo	CHIEF FINANCIAL OFFICER	SELL	4.117K	$4.91	$20K
Aug 18, 2026	Nolan Richard Townsend	CHIEF EXECUTIVE OFFICER	SELL	3.345K	$4.95	$17K
Aug 18, 2026	Manuel Jose Otero	CHIEF OPERATING OFFICER	SELL	1.304K	$4.96	$6K
Jun 29, 2026	Edward Louis Tamayo	CHIEF FINANCIAL OFFICER	GRANT	7.359K	$4.49	$21K
Jun 29, 2026	Manuel Jose Otero	CHIEF OPERATING OFFICER	GRANT	7.394K	$4.48	$21K
Jun 29, 2026	Pal Narinder Bhalla	CHIEF MEDICAL OFFICER	GRANT	32.694K	$4.42	$99K
Jun 29, 2026	Nolan Richard Townsend	CHIEF EXECUTIVE OFFICER	GRANT	41.053K	$4.48	$116K
May 18, 2026	Manuel Jose Otero	CHIEF OPERATING OFFICER	SELL	1.302K	$5.07	$7K
May 18, 2026	Nolan Richard Townsend	CHIEF EXECUTIVE OFFICER	SELL	3.342K	$5.06	$17K